Calcium Fumarate

Calcium fumarate is a calcium salt of fumaric acid that delivers approximately 25-30% elemental calcium by weight, releasing Ca²⁺ ions absorbed primarily in the small intestine via active transcellular transport mediated by TRPV6 channels. The fumarate anion enters the citric acid cycle as a direct intermediate, potentially offering a metabolic advantage over simpler calcium salts.

Origin & History

Calcium fumarate is a calcium salt of fumaric acid, a naturally occurring compound found in the citric acid cycle and plants like bolete mushrooms and Iceland moss. It is synthesized industrially by reacting calcium hydroxide or carbonate with fumaric acid, with a molecular formula of C₄H₂CaO₄ and molecular weight of 154.13 g/mol.

Historical & Cultural Context

No historical context in traditional medicine systems is documented for calcium fumarate, as it is a modern synthetic compound rather than a plant-derived remedy. Fumaric acid itself has limited traditional use, but not as the calcium salt.

Health Benefits

• Provides elemental calcium (25-30% by weight) for bone mineralization and skeletal health - evidence quality: general calcium research only
• Supports muscle contraction and nerve signaling through Ca²⁺ ion delivery - evidence quality: biochemical mechanism only
• Contributes to cellular energy metabolism via fumarate's role in the TCA cycle - evidence quality: theoretical based on biochemistry
• Essential for enzyme activation through calcium-dependent processes like calmodulin pathways - evidence quality: general calcium function
• May offer better bioavailability than inorganic calcium forms due to organic salt structure - evidence quality: theoretical, no specific studies

How It Works

Upon dissolution, calcium fumarate dissociates into Ca²⁺ and fumarate²⁻ ions; calcium is absorbed transcellularly via TRPV6 (epithelial calcium channel) in the duodenum and jejunum, facilitated by calbindin-D9k, then extruded basolaterally by PMCA1b (plasma membrane Ca²⁺-ATPase). Ca²⁺ activates calmodulin-dependent kinases, supports hydroxyapatite crystal formation in osteoblasts, and triggers actomyosin crossbridge cycling in skeletal and cardiac muscle. The fumarate anion is converted by fumarase to L-malate within the mitochondrial TCA cycle, theoretically contributing to ATP synthesis and reducing oxidative metabolic burden.

Scientific Research

No human clinical trials, RCTs, or meta-analyses specifically on calcium fumarate were identified in the research. PubChem entries list general literature but no dedicated PubMed PMIDs for calcium fumarate trials. Research focuses on its role as a calcium supplement without specific outcome studies on this form.

Clinical Summary

No published randomized controlled trials have investigated calcium fumarate specifically as a standalone intervention; current evidence is extrapolated from broad calcium supplementation research and in vitro biochemistry. Large trials such as the Women's Health Initiative (n=36,282) established that calcium supplementation at 1,000 mg/day increases bone mineral density by approximately 1-2% over 7 years, but used calcium carbonate and citrate, not fumarate. Fumaric acid derivatives have been studied independently in dermatology and neuroprotection contexts, but these findings are not transferable to calcium fumarate's calcium-delivery function. The evidence base for calcium fumarate specifically must therefore be rated as preliminary, with no quantified outcome data unique to this salt form.

Nutritional Profile

Calcium Fumarate (CaC4H2O4) is a calcium salt of fumaric acid with a molecular weight of approximately 172.1 g/mol. Elemental calcium content: 23.3% by weight (approximately 233 mg calcium per 1000 mg compound), positioning it as a moderate-density calcium source compared to calcium carbonate (40%) but comparable to calcium citrate (21%). The fumarate anion constitutes approximately 76.7% by weight. As a pure mineral salt, it contains no macronutrients (zero protein, fat, or carbohydrate contribution at supplemental doses), no dietary fiber, and no vitamins. Bioactive components: (1) Ca²⁺ ions — essential macromineral contributing to the recommended daily intake of 1000–1200 mg elemental calcium for adults; (2) Fumarate anion — a four-carbon dicarboxylate that is an endogenous intermediate of the citric acid cycle (TCA cycle), present at supplemental doses typically ranging from 500–1500 mg of the compound per serving. Bioavailability notes: Calcium fumarate is water-soluble to a limited degree (slightly soluble, superior to calcium carbonate), suggesting it does not require gastric acid for initial dissociation to the same extent as carbonate forms, potentially offering modest bioavailability advantages in achlorhydric individuals; however, direct comparative bioavailability studies against calcium citrate or carbonate are not available in published literature. Fumarate absorption occurs via intestinal dicarboxylate transporters (NaDC family), though the physiological significance of supplemental fumarate doses entering systemic TCA cycle metabolism remains theoretical. No appreciable micronutrient co-factors or fat-soluble compounds are present in this ingredient.

Preparation & Dosage

No clinically studied dosage ranges for calcium fumarate are detailed in available research. It is used as a food supplement providing elemental calcium (about 25-30% by weight), but without study-backed protocols. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Vitamin D3, Vitamin K2, Magnesium, Phosphorus, Boron

Safety & Interactions

Calcium fumarate shares the general safety profile of calcium salts; doses exceeding 2,500 mg elemental calcium daily are associated with hypercalcemia, nephrolithiasis, and, based on some meta-analyses, potential increased cardiovascular risk. It may reduce absorption of tetracycline antibiotics, fluoroquinolones, bisphosphonates, levothyroxine, and iron by forming insoluble complexes in the GI tract, requiring separation of doses by at least 2 hours. Patients with hypercalcemia, severe renal impairment (CrCl <30 mL/min), or calcium oxalate kidney stones should avoid supplemental calcium without medical supervision. Pregnancy is generally considered safe at RDA levels (1,000-1,300 mg elemental calcium daily), but the fumarate component has not been independently evaluated for fetal safety.